Cargando…
Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma
OBJECTIVE: To investigate the activation of the IFNγ signaling pathway in monocytes of patients with secondary hemophagocytic lymphohistiocytosis (sHLH)/macrophage activation syndrome (MAS) and to evaluate whether levels of phosphorylated STAT1 represent a biomarker for the identification of patient...
Autores principales: | Pascarella, Antonia, Bracaglia, Claudia, Caiello, Ivan, Arduini, Alessia, Moneta, Gian Marco, Rossi, Marianna Nicoletta, Matteo, Valentina, Pardeo, Manuela, De Benedetti, Fabrizio, Prencipe, Giusi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010171/ https://www.ncbi.nlm.nih.gov/pubmed/33815425 http://dx.doi.org/10.3389/fimmu.2021.663329 |
Ejemplares similares
-
The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis
por: Prencipe, Giusi, et al.
Publicado: (2019) -
IFNAR2 Deficiency Causing Dysregulation of NK Cell Functions and Presenting With Hemophagocytic Lymphohistiocytosis
por: Passarelli, Chiara, et al.
Publicado: (2020) -
An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Arduini, Alessia, et al.
Publicado: (2019) -
Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis
por: Bracaglia, C, et al.
Publicado: (2015) -
Neutralization of Interferon-gamma is efficacious in a mouse model of HLH secondary to chronic inflammation
por: Prencipe, G, et al.
Publicado: (2015)